Back to Search
MERRILL SAWYER, PHARMD
PHARMD
Pharmacist
NPI: 1679805840Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Phase I study of an oral formulation of ZD9331 administered daily for 28 days.
PMID 12721264·J Clin Oncol·2003
3-trial
Body surface area as a determinant of pharmacokinetics and drug dosing.
PMID 11392451·Invest New Drugs·2001
6-review
Cytotoxic activity of gemcitabine in cultured cell lines derived from histologically different types of bladder cancer: role of thymidine kinase 2.
PMID 19660438·Biochem Pharmacol·2010
4-observational
Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment.
PMID 19351764·Clin Cancer Res·2009
8-other
Development and validation of a bedside score to predict early death in cancer of unknown primary patients.
PMID 19649260·PLoS One·2009
4-observational
The prevalence and correlates of hallucinations in Australian adolescents: results from a national survey.
PMID 19046858·Schizophr Res·2009
8-other
Prophylactic ciprofloxacin treatment prevented high mortality, and modified systemic and intestinal immune function in tumour-bearing rats receiving dose-intensive CPT-11 chemotherapy.
PMID 19401694·Br J Cancer·2009
7-preclinical
Multicenter study of nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in children being evaluated for sexual abuse.
PMID 19451856·Pediatr Infect Dis J·2009
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2818 NEUSE BLVD
NEW BERN, NC 28562 - Phone
- (252) 636-4910
Quick Facts
- NPI
- 1679805840
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile